Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

MIP 2007C implantable insulin pump

Intraperitoneal insulin infusion delivered by an implantable pump: MIP 2007c

DEVICE

continuous subcutaneous insulin infusion (CSII) or MDI

Trial Locations (1)

8000 GM

Isala Klinieken, Zwolle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Medical Research Foundation, The Netherlands

OTHER